<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Thromboelastography | HE</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Thromboelastography (TEG)  Definition: Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) are viscoelastic hemostatic assays that provide a comprehensive assessment of...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Thromboelastography | HE">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Thromboelastography (TEG)  Definition: Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) are viscoelastic hemostatic assays that provide a comprehensive assessment of...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Thromboelastography | HE">
<meta name="twitter:description" content="Overview of Thromboelastography (TEG)  Definition: Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) are viscoelastic hemostatic assays that provide a comprehensive assessment of...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><link rel="icon" type="image/png" href="imgs/favicon.png">
<meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary-1.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="active" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Microbiology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="thromboelastography" class="section level1 unnumbered">
<h1>Thromboelastography<a class="anchor" aria-label="anchor" href="#thromboelastography"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-thromboelastography-teg" class="section level2 unnumbered">
<h2>
<strong>Overview of Thromboelastography (TEG)</strong><a class="anchor" aria-label="anchor" href="#overview-of-thromboelastography-teg"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) are viscoelastic hemostatic assays that provide a comprehensive assessment of hemostasis, including:
<ul>
<li>Coagulation: The formation of fibrin clot</li>
<li>Platelet Function: The contribution of platelets to clot strength</li>
<li>Fibrinolysis: The breakdown of the clot</li>
</ul>
</li>
<li>
<strong>Principle:</strong>
<ul>
<li>Whole Blood Analysis: TEG analyzes the entire coagulation process in whole blood, providing a more comprehensive assessment of hemostasis than traditional plasma-based coagulation tests (PT and aPTT)</li>
<li>Viscoelastic Measurements: Measures the viscoelastic properties of the developing clot over time, including:
<ul>
<li>Clot Strength</li>
<li>Clotting Time</li>
<li>Fibrinolysis</li>
</ul>
</li>
<li>Dynamic Assessment: Provides a dynamic assessment of clot formation and breakdown, reflecting the interactions between coagulation factors, platelets, and fibrinolytic proteins</li>
</ul>
</li>
<li>
<strong>Clinical Significance:</strong>
<ul>
<li>Assessment of Bleeding Risk: Helps identify patients at risk of bleeding during surgery or other invasive procedures</li>
<li>Goal-Directed Hemostatic Therapy: Guides the use of blood products and hemostatic agents in bleeding patients</li>
<li>Monitoring Anticoagulation: Can be used to monitor the effects of anticoagulants</li>
<li>Diagnosis of Coagulation Disorders: Can help identify inherited or acquired coagulation disorders</li>
<li>Assessment of Trauma-Induced Coagulopathy: Useful for assessing coagulopathy in trauma patients</li>
</ul>
</li>
<li>
<strong>Instruments:</strong>
<ul>
<li>Thromboelastograph (TEG): Older technology, measures the movement of a pin suspended in a cup of whole blood</li>
<li>Rotational Thromboelastometry (ROTEM): Newer technology, measures the rotation of a pin suspended in a cup of whole blood</li>
</ul>
</li>
</ul>
</div>
<div id="components-of-the-tegrotem-system" class="section level2 unnumbered">
<h2>
<strong>Components of the TEG/ROTEM System</strong><a class="anchor" aria-label="anchor" href="#components-of-the-tegrotem-system"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Instrumentation:</strong></p>
<ul>
<li>TEG or ROTEM Analyzer: The instrument that performs the viscoelastic measurements</li>
<li>Cups and Pins: Disposable cups and pins that are used to hold the blood sample and measure clot formation</li>
<li>Pipettes: Accurate pipettes for measuring reagents and samples</li>
<li>Temperature Control: System to maintain the sample at a constant temperature (typically 37°C)</li>
</ul>
</li>
<li>
<p><strong>Reagents:</strong></p>
<ul>
<li>Activators: Reagents that activate the coagulation cascade
<ul>
<li>Kaolin: A contact activator that initiates the intrinsic pathway</li>
<li>Tissue Factor (TF): Activates the extrinsic pathway</li>
<li>Ellagic Acid: Activates the contact pathway</li>
</ul>
</li>
<li>Inhibitors (Optional): Used to assess specific components of the coagulation system
<ul>
<li>Cytochalasin D: Inhibits platelet function</li>
<li>Aprotinin: Inhibits fibrinolysis</li>
</ul>
</li>
<li>Quality Control Materials: Commercially available control materials are used to monitor the performance of the instrument</li>
</ul>
</li>
<li>
<p><strong>Sample Preparation:</strong></p>
<ul>
<li>Whole Blood Collection:
<ul>
<li>Collect whole blood in a specialized tube recommended by the manufacturer (typically a citrate tube with a specific formulation)</li>
<li>Ensure that the tube is filled to the correct volume to maintain the proper blood-to-anticoagulant ratio</li>
<li>Gentle Mixing: Gently invert the collection tube 5-10 times to mix the blood with the anticoagulant</li>
</ul>
</li>
<li>Timely Analysis:
<ul>
<li>Test the sample within the timeframe recommended by the manufacturer (typically within 1-4 hours of collection)</li>
<li>Store the sample at room temperature (22-25°C) until testing</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="procedure-for-performing-tegrotem" class="section level2 unnumbered">
<h2>
<strong>Procedure for Performing TEG/ROTEM</strong><a class="anchor" aria-label="anchor" href="#procedure-for-performing-tegrotem"><i class="fas fa-link"></i></a>
</h2>
<ol style="list-style-type: decimal">
<li>Sample Preparation:
<ul>
<li>Follow the instrument manufacturer’s instructions for sample preparation</li>
<li>Ensure that the blood sample is well-mixed and free of clots</li>
</ul>
</li>
<li>Reagent Preparation:
<ul>
<li>Prepare the reagents according to the manufacturer’s instructions</li>
<li>Ensure that the reagents are properly stored and are not expired</li>
</ul>
</li>
<li>Instrument Setup:
<ul>
<li>Turn on the instrument and allow it to warm up</li>
<li>Load the appropriate cups and pins into the instrument</li>
<li>Enter the patient information and test order into the instrument software</li>
</ul>
</li>
<li>Running the Assay:
<ul>
<li>Pipette a specific volume of the whole blood sample into the cup</li>
<li>Add the appropriate activator (e.g., kaolin or tissue factor) to the sample</li>
<li>Start the test and allow the instrument to perform the analysis</li>
<li>The instrument will continuously monitor the viscoelastic properties of the developing clot and generate a TEG or ROTEM tracing</li>
</ul>
</li>
</ol>
</div>
<div id="interpreting-tegrotem-results" class="section level2 unnumbered">
<h2>
<strong>Interpreting TEG/ROTEM Results</strong><a class="anchor" aria-label="anchor" href="#interpreting-tegrotem-results"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Key Parameters:</strong></p>
<ul>
<li>R (Reaction Time):
<ul>
<li>The time from the start of the test until the first evidence of clot formation (initial fibrin formation)</li>
<li>Represents the activity of the coagulation factors</li>
<li>Prolonged R: Indicates a deficiency or inhibition of coagulation factors</li>
</ul>
</li>
<li>K (Clot Formation Time):
<ul>
<li>The time from the end of R until the clot reaches a certain level of strength</li>
<li>Represents the rate of fibrin clot formation</li>
<li>Prolonged K: Suggests a deficiency or dysfunction of fibrinogen</li>
</ul>
</li>
<li>α (Alpha Angle):
<ul>
<li>The angle between the R and K parameters</li>
<li>Reflects the speed of clot formation</li>
<li>Decreased Alpha Angle: Suggests a deficiency or dysfunction of fibrinogen or platelets</li>
</ul>
</li>
<li>MA (Maximum Amplitude):
<ul>
<li>The maximum strength of the clot, reflecting the interaction of platelets and fibrin</li>
<li>Represents the contribution of platelets to clot strength</li>
<li>Low MA: Suggests thrombocytopenia or platelet dysfunction</li>
</ul>
</li>
<li>CI (Clotting Index):
<ul>
<li>A global measure of hemostasis</li>
</ul>
</li>
<li>LY30 (Lysis at 30 Minutes):
<ul>
<li>The percentage decrease in clot amplitude 30 minutes after MA</li>
<li>Reflects the degree of fibrinolysis</li>
<li>Increased LY30: Suggests hyperfibrinolysis</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Interpretation Based on Specific Clinical Scenarios:</strong></p>
<ul>
<li>Bleeding Patient:
<ul>
<li>Prolonged R: Factor deficiency (e.g., hemophilia)</li>
<li>Prolonged K or Decreased α: Fibrinogen deficiency or dysfunction</li>
<li>Low MA: Thrombocytopenia or platelet dysfunction</li>
<li>Increased LY30: Hyperfibrinolysis (e.g., DIC)</li>
</ul>
</li>
<li>Thrombotic Patient:
<ul>
<li>Shortened R and K: Hypercoagulability</li>
<li>Increased MA: Increased platelet reactivity</li>
<li>Decreased LY30: Impaired fibrinolysis</li>
</ul>
</li>
<li>Monitoring Anticoagulation:
<ul>
<li>Heparin: Prolonged R and K, normal MA and LY30</li>
<li>Direct Thrombin Inhibitors: Prolonged R and K, normal MA and LY30</li>
<li>Fibrinolytic Agents: Increased LY30</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="factors-affecting-tegrotem-results" class="section level2 unnumbered">
<h2>
<strong>Factors Affecting TEG/ROTEM Results</strong><a class="anchor" aria-label="anchor" href="#factors-affecting-tegrotem-results"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Pre-Analytical Variables:</strong></p>
<ul>
<li>Improper Collection Technique: Tissue thromboplastin contamination or hemolysis</li>
<li>Clotted Sample: Invalidates the results</li>
<li>Delayed Testing: Coagulation factors and platelets can degrade over time</li>
<li>Improper Storage: Incorrect storage temperatures can affect results</li>
</ul>
</li>
<li>
<p><strong>Analytical Variables:</strong></p>
<ul>
<li>Instrument Malfunction: Ensure proper calibration and maintenance of the analyzer</li>
<li>Reagent Problems: Use fresh, properly stored reagents and follow the manufacturer’s instructions</li>
<li>Air Bubbles: Avoid introducing air bubbles into the sample or reagents</li>
<li>Temperature: Maintain a constant temperature (37°C) during the assay</li>
</ul>
</li>
<li>
<p><strong>Patient-Related Variables:</strong></p>
<ul>
<li>Medications: Anticoagulants, antiplatelet agents, and other medications can affect TEG/ROTEM results</li>
<li>Underlying Medical Conditions: Liver disease, kidney disease, and other conditions can affect coagulation and fibrinolysis</li>
<li>Hypothermia: Can prolong clotting times</li>
<li>Hemodilution: Can affect results in trauma patients</li>
</ul>
</li>
</ul>
</div>
<div id="troubleshooting-erroneous-results-11" class="section level2 unnumbered">
<h2>
<strong>Troubleshooting Erroneous Results</strong><a class="anchor" aria-label="anchor" href="#troubleshooting-erroneous-results-11"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p>If the TEG/ROTEM results are unexpected or inconsistent with the patient’s clinical presentation:</p>
<ul>
<li>Check the sample for clots or hemolysis</li>
<li>Repeat the test on a fresh sample</li>
<li>Verify the instrument and reagent quality control results</li>
<li>Ensure that the sample and reagents were handled and stored properly</li>
<li>Review the patient’s medication list and medical history</li>
<li>Consult with a pathologist or coagulation expert</li>
</ul>
</li>
</ul>
</div>
<div id="reflex-testing-7" class="section level2 unnumbered">
<h2>
<strong>Reflex Testing</strong><a class="anchor" aria-label="anchor" href="#reflex-testing-7"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p>If the TEG/ROTEM results are abnormal, additional testing may be performed to:</p>
<ul>
<li>Identify specific factor deficiencies: Factor assays</li>
<li>Detect platelet function defects: Platelet aggregation studies, flow cytometry</li>
<li>Quantify fibrinolysis: D-dimer assay, plasminogen activator inhibitor-1 (PAI-1) assay</li>
<li>Assess heparin or direct thrombin inhibitor (DTI) levels</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-96" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-96"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Thromboelastography (TEG):</strong> A viscoelastic hemostatic assay that measures clot formation, strength, and breakdown</li>
<li>
<strong>Rotational Thromboelastometry (ROTEM):</strong> A similar viscoelastic hemostatic assay that uses a different type of instrument</li>
<li>
<strong>R (Reaction Time):</strong> Time to initial clot formation</li>
<li>
<strong>K (Clot Formation Time):</strong> Time to reach a certain clot strength</li>
<li>
<strong>α (Alpha Angle):</strong> Rate of clot formation</li>
<li>
<strong>MA (Maximum Amplitude):</strong> Maximum clot strength</li>
<li>
<strong>CI (Clotting Index):</strong> A global measure of hemostasis</li>
<li>
<strong>LY30 (Lysis at 30 Minutes):</strong> Percentage decrease in clot amplitude 30 minutes after MA</li>
<li>
<strong>Hypercoagulability:</strong> An increased tendency to clot</li>
<li>
<strong>Hypofibrinolysis:</strong> Decreased breakdown of fibrin clots</li>
<li>
<strong>Hyperfibrinolysis:</strong> Excessive breakdown of fibrin clots</li>
<li>
<strong>Point of Care Testing (POCT):</strong> Performance of laboratory tests at or near the site of patient care</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? l.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="platelet-aggregation.html">Platelet Aggregation</a></div>
<div class="next"><a href="hypercoagulability.html">Hypercoagulability</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#thromboelastography">Thromboelastography</a></li>
<li><a class="nav-link" href="#overview-of-thromboelastography-teg">Overview of Thromboelastography (TEG)</a></li>
<li><a class="nav-link" href="#components-of-the-tegrotem-system">Components of the TEG/ROTEM System</a></li>
<li><a class="nav-link" href="#procedure-for-performing-tegrotem">Procedure for Performing TEG/ROTEM</a></li>
<li><a class="nav-link" href="#interpreting-tegrotem-results">Interpreting TEG/ROTEM Results</a></li>
<li><a class="nav-link" href="#factors-affecting-tegrotem-results">Factors Affecting TEG/ROTEM Results</a></li>
<li><a class="nav-link" href="#troubleshooting-erroneous-results-11">Troubleshooting Erroneous Results</a></li>
<li><a class="nav-link" href="#reflex-testing-7">Reflex Testing</a></li>
<li><a class="nav-link" href="#key-terms-96">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Microbiology/blob/blob/main/Rmd/05-24-hemostasis-laboratory-thromboelastography.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Microbiology/blob/edit/main/Rmd/05-24-hemostasis-laboratory-thromboelastography.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->


</body>
</html>
